Previous studies have demonstrated that simultaneously high CD47 and positive PD-L1 expression on tumor cells could synergistically promote tumor development, and that dual-blockade could achieve better anti-tumor effects than single blockade of CD47 or PD-L1 [12, 38]. The gene discussed is CD274; the disease is neoplasm.